Pharmaceutical

STAT+: Pharmalittle: Woodcock to retire from the FDA; A...

A FDA advisory panel urged Acrotech Biopharma to accelerate the release of trial...

The return of biotech’s “bump factor” amid an economic ...

Want to stay on top of the science and politics driving biotech today? Sign up t...

Opinion: We tried to quantify how harmful hospital rans...

Three health economists tried to quantify exactly how much hospital ransomware a...

Preterm birth and infant mortality measures in U.S. rem...

In the U.S., 14.6% of Black babies were born preterm, compared to 9.4% of white ...

STAT+: Even as Wegovy rides high, interest surges in we...

Drugs like Wegovy and Zepbound lead to both fat and muscle loss. An updated STAT...

STAT+: Doctors divide over reforming a secretive panel ...

Doctors are splitting, specialty by specialty, over whether and how to overhaul ...

STAT+: FDA’s Janet Woodcock to retire early next year

Principal Deputy FDA Commissioner Janet Woodcock will retire early next year fro...

Key questions (and answers) about the historic approval...

Here are some key questions (and answers) about the historic approval of a CRISP...

Listen: A CRISPR milestone, algorithms amok, & biotech ...

This week on "The Readout LOUD" podcast: A CRISPR milestone, algorithms amok, an...

Colon cancer screening kits have a high rate of untesta...

More than 10% of the tests used for routine colorectal cancer screening containe...

Report: Measles cases and deaths increase worldwide, as...

A dangerous decline in the rate of children vaccinated against measles is spurri...

STAT+: FDA cites Dr. Reddy’s for quality control proble...

Dr. Reddy’s Laboratories, one of the world’s largest generic drugmakers, was cit...

Progress in childhood cancer has stalled for Blacks and...

The overall cancer death rate for children and teenagers in the U.S. in 2021 was...

STAT+: Pharmalittle: U.K. approves world’s first CRISPR...

U.K. regulators approved a CRISPR-based medicine to treat sickle cell disease an...

How do we know Alzheimer’s drugs ‘work’?

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Bristol wins U.S. approval for lung cancer drug ...

The Food and Drug Administration on Wednesday approved a new treatment for peopl...